Evidence map›Paper›PMID 36407159›Full record

ReviewCureus2022

An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management.

Muhammad Atif Ameer, Haroon Chaudhry, Javaria Mushtaq, Osama S Khan, Maham Babar, Tehmina Hashim, Saima Zeb, Muhammad Ali Tariq, Sridhar Reddy Patlolla, Junaid Ali and 2 more

2 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 231 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 6 pooled it
48.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06631404 recruitingnot on this mapstarted 2024, after this paper: background citation

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

TypeobservationalSponsorSohag UniversityRan2024 to 2025Enrolled55ConditionsLupus NephritisArmsrenal doppler
NCT07017868 recruitingnot on this mapstarted 2025, after this paper: background citation

Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients

TypeobservationalSponsorSohag UniversityRan2025 to 2026Enrolled120ConditionsHomocysteine Level and Interleukin- 17 in Lupus Nephritis PatientsArmsinterleukin- 17
3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 6 syntheses or guidelines pooled it, 302 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Muhammad Atif AmeerDepartment of Medicine, Punjab Rangers Teaching Hospital, Lahore, PAK.
Haroon ChaudhryInternal Medicine, Suburban Community Hospital, East Norriton, USA.
Javaria MushtaqCell Biology and Neurosciences, Rowan University, Stratford, USA.
Osama S KhanSurgery, Khyber Medical University, Peshawar, PAK.
Maham BabarDepartment of Internal Medicine, Khyber Medical University, Peshawar, PAK.
Tehmina HashimPathology, Batterjee Medical College, Jeddah, SAU.
Saima ZebBiochemistry, Northwest School of Medicine, Peshawar, PAK.
Muhammad Ali TariqAngiocore Lab, Medstar Washington Hospital Center, Washington D.C., USA.
Sridhar Reddy PatlollaInternal Medicine, Suburban Community Hospital, East Norriton, USA.
Junaid AliDepartment of Medicine, Khyber Teaching Hospital, Peshawar, PAK.
Syeda Nafeesa HashimMedicine, Batterjee Medical College, Jeddah, SAU.
Sana HashimMedicine and Surgery, Batterjee Medical College, Jeddah, SAU.
Khyber Teaching Hospital · PKPakistan Army · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem involvement. It is multifactorial and involves epigenetic, genetic, ecological, and environmental factors. Primarily it leads to activation of both innate and adaptive immunity, which consequently leads to autoreactive B cell activation by T cells and leads to immune complexes deposition in tissues leading to an autoimmune cascade that may be limited to the single organ or can cause a widespread systemic involvement. SLE is heterogeneous in presentation, with a broad spectrum of clinical manifestations ranging from clinically mild self-resolving symptoms to severe life-threatening organ involvement. Clinical and serological heterogeneity are critical features in SLE, posing a significant challenge in its diagnosis. Antinuclear antibodies (ANA) are the telltale serological marker in more than 95% of SLE patients. The improved set of European Alliance of Associations for Rheumatology (EULAR) classification enabled accurate diagnosis of SLE. The treatment focuses on remission, preventing organ damage, and improving the overall quality of life.

Indexed as

comorbids of sleconstitutional symptoms and sleeuropean alliance of associations for rheumatology (eular) classificationlupus nephritispathogenesis of slepreclinical lupusslesle and lupus nephritissystemic lupus erythematosis

Identifiers

PMID36407159
PMCPMC9662848
OpenAlexW4306315823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.